Bronchoscopy pathology outcome
| Bronchoscopy pathology outcome | Target tumour | Secondary lesions | Control biopsies | |||
| N | % | N | % | N | % | |
| Pathology outcome | 107 | 51 | 53 | |||
| Normal | – | – | 15 | 29 | 33 | 62 |
| Inflammation | – | – | 17 | 33 | 19 | 36 |
| Hyperplasia | – | – | 2 | 4 | – | – |
| Squamous metaplasia | – | – | 3 | 6 | 1 | 2 |
| Mild dysplasia | – | – | 3 | 6 | – | – |
| Moderate dysplasia | – | – | 0 | 0 | – | – |
| Severe dysplasia | – | – | 1 | 2 | – | – |
| CIS | – | – | 1 | 2 | – | – |
| Invasive carcinoma | 107 | 100 | 9 | 18 | – | – |
| NSCLC—SqCC | 43 | 40 | 1 | 2 | – | – |
| NSCLC—AC | 39 | 36 | 7 | 14 | – | – |
| NSCLC—LCNOS | 5 | 5 | – | – | – | – |
| LCNEC | 2 | 2 | – | – | – | – |
| SCLC | 11 | 10 | – | – | – | – |
| Typical carcinoid | 6 | 6 | – | – | – | – |
| Mucoepidermoid cell carcinoma | 1 | 1 | – | – | – | – |
| LGSDC* | – | – | 1 | 2 | – | – |
*Published as case report.18
AC, adenocarcinoma; CIS, carcinoma in situ; LCNEC, large cell neuroendocrine carcinoma; LCNOS, large cell not otherwise classified; LGSDC, low-grade salivary duct cell carcinoma; NSCLC, non-small cell lung cancer, SCLC, small cell lung cancer; SqCC, squamous cell carcinoma.